| Cause-specific survival | Overall survival | ||||||
---|---|---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||
Characteristics | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P |
Adjuvant treatment | ||||||||
 CRT | Reference |  |  |  | Reference |  |  |  |
 RT alone | 0.94 (0.82–1.81) | 0.384 | 1.48 (1.25–1.74) |  < 0.001 | 1.11 (0.98–1.26) | 0.104 | 1.64 (1.42–1.89) |  < 0.001 |
Age group (years) | ||||||||
 < 50 | Reference |  |  |  | Reference |  |  |  |
 50–65 | 1.03 (0.70–1.49) | 0.896 | 0.99 (0.68–1.46) | 0.981 | 0.93 (0.65–1.34) | 0.707 | 1.15 (0.80–1.65) | 0.459 |
  > 65 | 1.29 (1.15–1.46) |  < 0.001 | 1.32 (0.90–1.94) | 0.153 | 1.40 (1.26–1.56) | 0.024 | 1.60 (1.11–2.30) | 0.011 |
Year of diagnosis | ||||||||
 2004–2008 | Reference |  |  |  | Reference |  |  |  |
 2009–2013 | 0.90 (0.77–1.05) | 0.164 | 0.91 (0.78–1.08) | 0275 | 0.88 (0.76–1.01) | 0.061 | 0.92 (0.80–1.07) | 0.271 |
 2014–2018 | 0.85 (0.73–0.99) | 0.036 | 0.87 (0.73–1.03) | 0.114 | 0.82 (0.71–0.94) | 0.005 | 0.87 (0.74–1.02) | 0.093 |
Race redode | ||||||||
 Black | Reference |  |  |  | Reference |  |  |  |
 Othersa | 0.64 (0.49–0.83) | 0.001 | 0.58 (0.45–0.76) |  < 0.001 | 0.71 (0.56–0.89) | 0.004 | 0.69 (0.54–0.88) | 0.002 |
 White | 0.84 (0.73–0.97) | 0.015 | 0.83 (0.71–0.96) | 0.010 | 0.86 (0.75–0.97) | 0.017 | 0.85 (0.75–0.98) | 0.023 |
Marital status | ||||||||
 Divorced/separated | Reference |  |  |  | Reference |  |  |  |
 Married | 0.92 (0.77–1.10) | 0.347 | 1.03 (0.85–1.23) | 0.779 | 0.90 (0.76–1.06) | 0.190 | 1.01 (0.85–1.19) | 0.907 |
 Single/unmarried | 0.94 (0.75–1.17) | 0.557 | 0.92 (0.73–1.15) | 0.462 | 0.95 (0.77–1.16) | 0.588 | 0.95 (0.77–1.17) | 0.620 |
 Unknown | 0.81 (0.58–1.12) | 0.197 | 0.77 (0.56–1.07) | 0.125 | 0.85 (0.63–1.15) | 0.292 | 0.82 (0.61–1.11) | 0.202 |
 Widowed | 1.21 (0.99–1.49) | 0.067 | 1.16 (0.94–1.44) | 0.169 | 1.34 (1.11–1.61) | 0.002 | 1.24 (1.02–1.50) | 0.030 |
Median household income | ||||||||
 < $50,000 | Reference |  |  |  | Reference |  |  |  |
 $50,000–65,000 | 1.07 (0.88–1.29) | 0.495 | 1.09 (0.90–1.32) | 0.371 | 1.11 (0.93–1.31) | 0.241 | 1.05(0.89–1.25) | 0.549 |
  > $65,000 | 0.80 (0.71–0.91) | 0.001 | 0.93 (0.770–1.111) | 0.405 | 0.79 (0.70–0.88) |  < 0.001 | 0.87 (0.74–1.03) | 0.101 |
Grade | ||||||||
 I | Reference |  |  |  | Reference |  |  |  |
 II | 1.22 (0.61–2.45) | 0.568 | 1.19 (0.59–2.39) | 0.631 | 1.10 (0.63–1.91) | 0.743 | 1.09 (0.62–1.90) | 0.773 |
 III | 1.79 (0.96–3.35) | 0.067 | 1.67 (0.89–3.13) | 0.112 | 1.33 (0.81–2.19) | 0.256 | 1.30 (0.79–2.14) | 0.310 |
 IV | 1.73 (0.92–3.24) | 0.089 | 1.55 (0.82–2.93) | 0.176 | 1.32 (0.80–2.17) | 0.282 | 1.24 (0.75–2.05) | 0.412 |
 Unknown | 1.44 (0.76–2.71) | 0.259 | 1.35 (0.71–2.56) | 0.358 | 1.10 (0.66–1.81) | 0.724 | 1.07 (0.64–1.78) | 0.797 |
Histology | ||||||||
 Clear cell | Reference |  |  |  | Reference |  |  |  |
 Serous | 1.36 (1.14–1.61) |  < 0.001 | 1.28 (1.07–1.53) | 0.005 | 1.25 (1.08–1.45) | 0.003 | 1.23(1.05–1.44) | 0.009 |
 Carcinosarcoma | 2.07 (1.63–2.61) |  < 0.001 | 2.01 (1.56–2.59) |  < 0.001 | 1.88 (1.52–2.33) |  < 0.001 | 1.87 (1.48–2.37) |  < 0.001 |
TNM stage | ||||||||
 T1N0M0 | Reference |  |  |  | Reference |  |  |  |
 T2N0M0 | 2.09 (1.69–2.59) |  < 0.001 | 1.95 (1.57–2.42) |  < 0.001 | 1.85 (1.53–2.23) |  < 0.001 | 1.72 (1.42–2.08) |  < 0.001 |
 T3-4aN0MO | 3.21 (2.66–3.87) |  < 0.001 | 3.191 (2.63–3.88) |  < 0.001 | 2.70 (2.29–3.19) |  < 0.001 | 2.72 (2.29–3.23) |  < 0.001 |
 TanyN1M0 | 3.68 (3.12–4.33) |  < 0.001 | 3.86 (3.24–4.61) |  < 0.001 | 3.09 (2.68–3.57) |  < 0.001 | 3.41 (2.92–3.99) |  < 0.001 |
 TanyN2M0 | 4.94 (3.65–6.69) |  < 0.001 | 4.92 (3.59–6.74) |  < 0.001 | 3.88 (2.90–5.21) |  < 0.001 | 4.08 (3.01–5.52) |  < 0.001 |
 TanyNanyM1 | 8.82 (7.28–10.67) |  < 0.001 | 8.67 (7.03–10.68) |  < 0.001 | 6.94 (5.82–8.27) |  < 0.001 | 6.94 (5.73–8.41) |  < 0.001 |
Surgery mode | ||||||||
 Total hysterectomy | Reference |  |  |  | Reference |  |  |  |
 Extended hysterectomy | 1.37 (1.14–1.64) | 0.001 | 1.05 (0.87–1.26) | 0.635 | 1.26 (1.07–1.50) | 0.007 | 0.99 (0.83–1.18) | 0.895 |
Lymphadenectomy | ||||||||
 Yes | Reference |  |  |  | Reference |  |  |  |
 No | 1.60 (1.37–1.87) |  < 0.001 | 1.34 (1.13–1.58) |  < 0.001 | 1.73 (1.50–1.99) |  < 0.001 | 1.46 (1.25–1.70) |  < 0.001 |
 SLN biopsy/removed | 0.91 (0.67–1.23) | 0.519 | 0.975 (0.716–1.327) | 0.871 | 0.89 (0.67–1.18) | 0.414 | 0.94 (0.70–1.26) | 0.685 |
Tumor Size (mm) | ||||||||
 < 20 | Reference |  |  |  | Reference |  |  |  |
 20–39 | 1.40 (1.10–1.77) | 0.006 | 1.14 (0.89–1.45) | 0.291 | 1.41 (1.13–1.75) | 0.002 | 1.19 (0.96–1.48) | 0.122 |
 40–59 | 2.09 (1.65–2.64) |  < 0.001 | 1.42 (1.12–1.81) | 0.003 | 1.99 (1.61–2.47) |  < 0.001 | 1.43 (1.15–1.78) | 0.001 |
 60–79 | 2.34 (1.80–3.03) |  < 0.001 | 1.34 (1.02–1.74) | 0.033 | 2.35 (1.86–2.98) |  < 0.001 | 1.42 (1.11–1.80) | 0.005 |
  ≥ 80 | 3.31 (2.57–4.26) |  < 0.001 | 1.74 (1.34–2.26) |  < 0.001 | 3.29 (2.61–4.15) |  < 0.001 | 1.87 (1.47–2.37) |  < 0.001 |
 Unknown | 1.62 (1.28–2.04) |  < 0.001 | 1.24 (0.98–1.57) | 0.076 | 1.65 (1.34–2.04) |  < 0.001 | 1.31 (1.06–1.62) | 0.014 |